Gilde Healthcare leads USD 20 million financing round of Belgian sleep therapy company Nyxoah

By on Juli 7, 2016

Target: Nyxoah S.A.

Dealtype: venture

Country: belgium

Branch: medical devices

Buyer: Gilde Healthcare, SRIW

Seller: –

Transaction: Nyxoah S.A., a medical device company focused on developing a neurostimulation based, disruptive therapy for patients suffering from Obstructive Sleep Apnea (OSA), announced today it has raised €18 million ($20 million) in fresh capital. The financing was led by Gilde Healthcare. SRIW and all existing shareholders also participated in the round. The proceeds will be used to finance Nyxoah’s go-to-market strategy, including CE Mark approval and the US FDA approval process….

Full article…

All Deals in Europe you can see HERE!


Mehr Informationen zu dieser und vielen anderen Transaktionen erhalten Sie HIER


Über 25.000 recherchierte Transaktionen seit 2005 - Legen Sie sich Ihre eigene Datenbank zu!